Health Check: Limited Visits to the GP as Patients Continue to Avoid Appointments Post-COVID

2 min read | February 23, 2025 11:00 AM AEDT | By Team Kalkine Media

Health Check: Limited Visits to the GP as Patients Continue to Avoid Appointments Post-COVID — Image source: shutterstock

EZZ Life Science Expands Product Offerings and Geographic Reach

EZZ Life Science, listed as ASX:EZZ, has strengthened its presence in the consumer health sector with an extensive lineup of product launches. The introduction of multiple new products within a short period has contributed to significant revenue and earnings growth.

Distribution channels have played a crucial role in EZZ’s market expansion, particularly through e-commerce platforms and established networks in key international regions. Strategic initiatives include plans for entry into new markets while maintaining brand visibility through high-profile events. These efforts align with the company’s broader approach to growth through product innovation and market engagement.

Vitura Health Responds to Market Conditions with Strategic Adjustments

Vitura Health, trading as ASX:VIT, operates within a competitive environment where pricing pressures have influenced financial outcomes. Increased product availability within the medical cannabis market has led to shifts in pricing structures, affecting overall margins.

In response, Vitura has focused on expanding its patient base and diversifying its offerings. Clinical consulting services have emerged as a key area of growth, contributing positively to overall revenue. The introduction of budget-friendly product lines aligns with the company’s broader strategy to adapt to evolving market conditions while maintaining service accessibility.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.